CN
87-26-3
应用筛选条件
关键词:'87-26-3'
显示 1-30 共 327 条结果 关于 "87-26-3" 范围 技术文档
User Guide - Milli-Q® IX - Chinese
55 60 87
ZIX7005T0C 30 48 55 65 89
ZIX7010T0C 30 48 55 78 95
ZIX7015T0C 30 48 55 90 100
根据下文描述的实验方法收集了以下数据：
• 每天产水5个小时或20个小时。
• 每次取水之前，手动循环一次（30秒）。
• 每次取水之后，手动循环一次（30秒）。
• 每小时自动循环3分钟。
• 开启
The Effective Use of Protein Kinase Inhibitors
86 98 58 68 46 7 97 22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93
Interactive Pathway Calendar
Saturday
1
4 7
2
5 8
3
6 9 10
17
24
31
16
23
30
Plant Growth
.soluble
R: 22-41-43-51/53 S: 24/25-26-36/37/39-46-61
3-Indoleacetic acid
5 g
25 g
100 g
I 2886
D
(Heteroauxin; 3-Indolylacetic acid; IAA)
CAS No. 87-51-4
C10H9NO2 FW 175.2
Plant cell culture
The Effective Use of Protein Kinase Inhibitors
86 98 58 68 46 7 97 22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93
Product Information Sheet - A2929
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A9952
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A9702
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A8455
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A0328
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A9414
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A9311
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A9668
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A0701
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A3054
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - A6560
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Anti-Connexin 40 - Data Sheet
sequence is conserved in human and rat
Cx40 (100%), chicken Cx42 (77%), human Cx50 (87%), rat Cx50 (81%) and sheep Cx49
(87%).
FORMAT:
Antibodies have been affinity-purified using peptide-Sepharose
Product Information Sheet - A9539
Agarose Type I-A: Low EEO
1200 at 1.0%
>2500 at 1.5%
36±1.5 at 1.5%
87±1.5
0.09-0.13
A0576
Agarose Type I-B:
Product Information Sheet - O8801
Ger. Offen. 2,554,148 (1977); Chem. Abstr., 87, 117683n (1977).
39 J.W. Scott, D.R. Parrish, and G. Saucy, U.S. Patent 4,018, 799 (1977); Chem. Abstr., 87, 68154e (1977).
LABORATORY NOTEBOOK ISSUANCE PAGE
114.818(3)
Iodine I 53 126.904 47(3)
Iridium Ir 77 192.217(3)
Iron Fe 26 55.845(2)
Krypton Kr 36 83.798(2)
Lanthanum La 57 138.905 47(7)
Lawrencium Lr 103 [262]
Lead Pb 82 207.2(1)
Lithium Li 3 [6.938;
LABORATORY NOTEBOOK ISSUANCE PAGE
114.818(3)
Iodine I 53 126.904 47(3)
Iridium Ir 77 192.217(3)
Iron Fe 26 55.845(2)
Krypton Kr 36 83.798(2)
Lanthanum La 57 138.905 47(7)
Lawrencium Lr 103 [262]
Lead Pb 82 207.2(1)
Lithium Li 3 [6.938;
LABORATORY NOTEBOOK ISSUANCE PAGE
114.818(3)
Iodine I 53 126.904 47(3)
Iridium Ir 77 192.217(3)
Iron Fe 26 55.845(2)
Krypton Kr 36 83.798(2)
Lanthanum La 57 138.905 47(7)
Lawrencium Lr 103 [262]
Lead Pb 82 207.2(1)
Lithium Li 3 [6.938;
Lab Notebook Guidelines
114.818(3)
Iodine I 53 126.904 47(3)
Iridium Ir 77 192.217(3)
Iron Fe 26 55.845(2)
Krypton Kr 36 83.798(2)
Lanthanum La 57 138.905 47(7)
Lawrencium Lr 103 [262]
Lead Pb 82 207.2(1)
Lithium Li 3 [6.938;
Data Sheet - P0747
activation. Eur. J. Immunol., 26, 1290-1296 (1996).
3. Skalhegg, B.S., et al., Location of cAMP-dependent
protein kinase type I with the TCR-CD3 complex.
Science., 263, 84-87 (1994)
AH/PHC 11/04
Product Information Sheet - P2277
USA, 87, 682-685 (1990).
33. Busse, R. and Mulsch, A. Febs Lett., 265, 133-136
(1990).
34. Watterson, D. et al., J. Biol. Chem., 251, 4501-4513
(1976).
35. Blum, J. et al., J. Cell Biol., 87, 386
Product Information Sheet - SE120139
Rev., 26, 21-32 (2005).
3. Bikle, D.D., Vitamin D and the skin. J. Bone Miner.
Metab., 28, 117-30 (2010).
4. Zerwekh, J.E., Blood biomarkers of vitamin D
status. Am. J. Clin. Nutr., 87, 1087S
Product Information Sheet - 186651
.
25 Sepp, D.T.; Scherer, K.V.; Weber, W.P. Tetrahedron Lett. 1974, 2983.
26 Chem. Eng. News, March 2, 1970, p 26.
27 Roeske, R.W.; Gesellchen, P.D. Tetrahedron Lett. 1976, 3369.
28 Leong
Product Information Sheet - K3375
Pharmacol., 154, 85-87 (1988).
5. Cannazza, G., et al., Changes in Kynurenic,
Anthranilic, and Quinolinic Acid concentrations in
rat brain tissue during development.
Neurochemical Research, 26, 511-514 (2001
Product Information Sheet - P4394
Eur. J. Cancer and Clin. Oncol.,
25, 27, (1989).
19. Burnouf, D. et al., Proc. Natl Acad. Sci., 87, 6087,
(1990).
20. Breusova-Baidala, Y. et al., Izv. Akad. Nauk SSSR,
Ser. Khim.
Data Sheet - L0915
Gearing, D., et al., EMBO J., 10, 2839 (1991).
2. Bazan, J.F., Proc. Natl. Acad. Sci. USA, 87, 6934
(1990).
3. Gearing, D.P., et al., Proc. Natl. Acad. Sci. USA, 91,
1119 (1994).
4. Pennica, D.
1/11